Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin for schizophrenia and schizoaffective disorder
NCT00177580Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Jul 2003
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pravastatin in schizophrenia and schizoaffective disorder (2 arms), sponsored by University of Pittsburgh. Primary endpoint: PANSS total score at 28 weeks. Started Jul 2003; status: completed.
02
Drugs
pravastatin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00177580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177580.